Internal Medicine, Cardiovascular Disease · Houston, TX
NPI
1598844870
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2727 W Holcombe Blvd
Houston, TX, 77025
Phone (713) 442-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,530
132 services
Medicare patients, 2024
67
Average age 74
Drug cost, 2024
$2.0M
10,646 prescriptions
Company payments, 2025
$149
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Madjid Mirzaitehrane was code 93010 (electrocardiogram), 24 times for 22 patients. In total Madjid Mirzaitehrane billed 132 services in 24 codes, and Medicare paid $6,530.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 24 | 22 | $5.88 | $141 |
| 99214 Office E&M - Established | Office | 18 | 14 | $84.69 | $1,524 |
| 93000 Electrocardiogram | Office | 14 | 13 | $9.83 | $138 |
By year: 2022 $6,117 for 143 services; 2023 $9,514 for 184 services; 2024 $6,530 for 132 services.
Medicare prescription drug claims, 2024
In 2024, the drug Madjid Mirzaitehrane prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,065 prescriptions and refills. In total Madjid Mirzaitehrane wrote 10,646 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,065 | 2,861 | 326 | $32K |
| Eliquis Apixaban | 894 | 1,634 | 226 | $897K |
| Metoprolol Succinate Generic | 815 | 2,116 | 240 | $17K |
| Amlodipine Besylate Generic | 525 | 1,458 | 184 | $4,482 |
| Losartan Potassium Generic | 466 | 1,264 | 158 | $11K |
| Carvedilol Generic | 460 | 1,240 | 161 | $7,453 |
| Rosuvastatin Calcium Generic | 430 | 1,163 | 137 | $19K |
| Ezetimibe Generic | 425 | 1,101 | 136 | $62K |
| Furosemide Generic | 407 | 1,028 | 139 | $2,256 |
| Entresto Sacubitril/Valsartan | 399 | 701 | 86 | $393K |
| Metoprolol Tartrate Generic | 374 | 948 | 117 | $3,996 |
| Amiodarone Hcl Generic | 349 | 954 | 129 | $9,156 |
| Valsartan Generic | 342 | 944 | 116 | $22K |
| Clopidogrel Clopidogrel Bisulfate | 333 | 882 | 110 | $8,137 |
| Spironolactone Generic | 292 | 832 | 97 | $3,513 |
Brand drugs: 1,820 claims; generic drugs: 8,826 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Madjid Mirzaitehrane $149 ($149 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abiomed with $118.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.